Category Archives: Salmonella in Chicken

Research -Holistic Strategies to Control Salmonella Infantis: An Emerging Challenge in the European Broiler Sector

MDPI

Abstract

Salmonella spp. has been globally recognized as one of the leading causes of acute human bacterial gastroenteritis resulting from the consumption of animal-derived products. Salmonella Enteritidis, S. Typhimurium, and its monophasic variant are the main serovars responsible for human disease. However, a serovar known as S. Infantis has emerged as the fourth most prevalent serovar associated with human disease. A total of 95% of isolated S. Infantis serovars originate from broilers and their derived products. This serovar is strongly associated with an elevated antimicrobial (AMR) and multidrug resistance, a resistance to disinfectants, an increased tolerance to environmental mercury, a heightened virulence, and an enhanced ability to form biofilms and attach to host cells. Furthermore, this serovar harbors genes that confer resistance to colistin, a last-resort antibiotic in human medicine, and it has the potential to acquire additional transferable AMR against other critically important antimicrobials, posing a new and significant challenge to global public health. This review provides an overview of the current status of the S. Infantis serovar in the poultry sector, focusing on its key virulence factors, including its virulence genes, antimicrobial resistance, and biofilm formation. Additionally, novel holistic strategies for controlling S. Infantis along the entire food chain are presented in this review.

Research – Inhibition of Salmonella Enteritidis by Essential Oil Components and the Effect of Storage on the Quality of Chicken

MDPI

Abstract

This research investigates the antibacterial potential of plant essential oil components including thymol, carvacrol, citral, cinnamaldehyde, limonene, and β-pinene against Salmonella Enteritidis (S. Enteritidis). Through the determination of minimum inhibitory concentration, three kinds of natural antibacterial agents with the best inhibitory effect on S. Enteritidis were determined, namely thymol (128 μg/mL), carvacrol (256 μg/mL), and cinnamaldehyde (128 μg/mL). Physical, chemical, microbial, and sensory characteristics were regularly monitored on days 0, 2, 4, and 6. The findings of this study reveal that both thymol at MIC of 128 μg/mL and carvacrol at MIC of 256 μg/mL not only maintained the sensory quality of chicken, but also decreased the pH, moisture content, and TVB-N value. Additionally, thymol, carvacrol and cinnamaldehyde successfully inhibited the formation of S. Enteritidis biofilm, thereby minimizing the number of S. Enteritidis and the total aerobic plate count in chicken. Hence, thymol, carvacrol, and cinnamaldehyde have more effective inhibitory activities against S. Enteritidis, which can effectively prevent the spoilage of chicken and reduce the loss of its functional components.

Belgium – Poultry hamburger – Salmonella

AFSCA

Recall from Fiers NV
Product: Poultry hamburger
Nature of the problem: presence of Salmonella

In agreement with the FASFC, Fiers NV withdraws the Poultry Hamburger from sale and recalls it from consumers due to the presence of Salmonella.
Fiers NV asks its customers not to consume this product and to return it to the point of sale where it was purchased, where it will be refunded.

Product description

– Product name: Poultry hamburger
– Brand: Fiers
– Use-by dates (BBD) (“Use by”): 04-07-2023 / 05-07-2023 / 06-07-2023
– Batch number: 79393 – 79553 – 79691
– Sales period: from 06/27/2023 to 06/29/2023
– Type of packaging: transparent plastic dish
– Weight: 2 pieces per packaging

06/07/2023
Recall from Fiers NV
Product: Poultry hamburger
Nature of the problem: presence of Salmonella


In agreement with the FASFC, Fiers NV withdraws the Poultry Hamburger from sale and recalls it from consumers due to the presence of Salmonella.
Fiers NV asks its customers not to consume this product and to return it to the point of sale where it was purchased, where it will be refunded.Product description

– Product name: Poultry hamburger
– Brand: Fiers
– Use-by dates (BBD) (“Use by”): 04-07-2023 / 05-07-2023 / 06-07-2023
– Batch number: 79393 – 79553 – 79691
– Sales period: from 06/27/2023 to 06/29/2023
– Type of packaging: transparent plastic dish
– Weight: 2 pieces per packaging

The product was distributed by:

CARREFOUR EXPRESS NIEUWPOORT Albert I Laan 213, 8620 Nieuwpoort
GB ZWIJNAARDE ZWIJNAARDSESTEENWEG 736, 9000 GENT
GB MARKET AALST Hovenierstraat 20, 9300 Aalst
Proxy Denderleeuw A. DE COCKSTRAAT 13, 9470 Denderleeuw

For any additional information , contact Mrs. Vandenheede; kwaliteit@fiers.net or 04778/493117

RASFF Alerts – Salmonella – Polish Chicken Products – Sesame Seeds – Sausage Sticks – Cheese

RASFF

Salmonella spp. in dried fish from Thailand via the Netherlands in Germany

RASFF

SALMONELLA IN SESAME SEEDS FROM Mali in Greece

RASFF

Salmonella spp. in a chicken quarter from Poland in Germany

RASFF

Salmonella Infantis in chicken breast fillets from Poland in the UAE and Lithuania

RASFF

Salmonella in sausage sticks from the Netherlands in Belgium

RASFF

Salmonella Enteritidis in chick fillet from Poland in Belgium, UK, France and the Netherlands

RASFF

Salmonella in cheese made with pasteurized cow and goat milk from Spain in Portugal

RASFF

Salmonella in sesame seeds from India in Poland

Greece – Gluten Free Chicken Burger and Chicken Souvlaki -Salmonella

EFET

E.F.E.T. and in particular the Regional Directorate of Central Macedonia, during inspections within the framework of the 2023 “Official Control of Microbiological Food Safety Criteria” Program, sampled frozen meat preparations with the following data: 1) GLUTEN-FREE CHICKEN BUTTER with a use-by date of 08/06/ 2024 and date of production / freezing 14/04/2023 and 2) SOUVLAKI CHICKEN, with date of consumption 31/08/2024 and date of production / freezing 09/05/2023 produced by the company “POULTRY ENTERPRISES A. KARAGIANNAKIS S.A. – Chicken Karagiannakis of Halkidiki”. Following laboratory analyzes in the laboratory of the Veterinary Center of Thessaloniki, the presence of the pathogenic microorganism Salmonella spp. in the above samples.

E.F.E.T. demanded the immediate recall of all the specific batches of the products in question and the relevant controls are already underway.

Consumers who have purchased the products in question (pictured above) are urged not to consume them.

USA – No reduction in human illnesses from poultry-caused Salmonella

Food Safety News

“While the prevalence of Salmonella contamination in regulated poultry products has decreased by more than 50 percent in recent years, there has not been a reduction in human illnesses attributable to poultry,” a new USDA report says.

USDA’s Food Safety and Inspection Service (FSIS) has released a survey of Not-Ready-to-Eat Breaded and Stuffed Chicken Products for Salmonella. The June report was prepared by FSIS’s Laboratory Quality Assurance, Response, and Coordination (LQARCS) staff in the Office of Public Health.

According to the survey report: “FSIS worked with the Food Emergency Response Network to test for the presence of Salmonella and sanitary indicator aerobic organism counts using the current validated methods employed by 11 state public health and agriculture laboratories. From July 1, 2022, to September 30, 2022, the laboratories purchased approximately 15 samples of the product per month from nearby retail locations.

Research – Bacillus subtilis PM5 from Camel Milk Boosts Chicken Immunity and Abrogates Salmonella entertitidis Infections

MDPI

Abstract

With the practice of a successful livestock industry using antibiotics, which has continued for more than five decades, researchers have long been interested in finding alternatives to antibiotics for poultry production. Probiotics can potentially reduce enteric diseases in livestock and enhance their productivity. The aim of this study was to isolate putative probiotics from camel milk and test them against Salmonella infection as well as host immune development. Thirteen different isolates were obtained from six different camel milk samples from dairy farms in Saudi Arabia. Three of the six isolates (PM1, PM2, PM3, PM4, PM5, and PM6) that showed Gram-positive characters reacted negatively to catalase and hemolytic assays. PM1, PM5, and PM6 showed significant nonpolar surface properties (>51% hydrophobic) and potent antimicrobial activities against avian pathogens, namely S. enterica, S. typhi, S. aureus, and E. coli. PM5 exhibited substantial probiotic traits; therefore, further focus was given to it. PM5 was identified as Bacillus subtilis OQ913924 by the 16S rRNA sequencing method and showed similarity matrix > 99%. An in vivo chicken model was used to access the health benefits of probiotics. After salmonella infection, the mucosal immune response was significantly increased (p < 0.01), and none of the challenge protocols caused mortality or clinical symptoms after infection in intestinal contents. S. enterica organ infiltration in the spleen, thymus, and small intestine was significantly reduced in the B. subtilis PM5-fed chickens. The S. enterica load in chicken feces was reduced from CFU 7.2 to 5.2 in oral-fed B. subtilis PM5-fed chickens. Probiotic-fed chickens showed buffered intestinal content and positively regulated the level of butyric acid (p < 0.05), and intestinal interleukin 1 beta (IL1-β), C-reactive protein (CRP), and interferon gamma (IFN-γ) levels were reduced (p < 0.05). In addition, B. subtilis PM5 showed significant binding to peritoneal macrophages cells and inhibited S. enterica surface adhesion, indicating co-aggregation of B. subtilis PM5 in macrophage cells. It could be concluded that supplementation with probiotics can improve the growth performance of broilers and the quality of broiler chickens against enteric pathogens. The introduction of this probiotic into the commercial poultry feed market in the near future may assist in narrowing the gap that now exists between chicken breeding and consumer demand.

Salmonella outbreak ongoing with 130 sick; Listeria incident over in UK

Food Safety News

Investigations into a Salmonella outbreak are ongoing but a Listeria outbreak has ended, according to the Food Standards Agency (FSA).

More than 130 people are sick with Salmonella Mbandaka after eating chicken products from Ukraine. Four patients were admitted to hospitals and one person died.

In response to repeated non-compliance with partly cooked chicken products from Ukraine, a system of Intensified Official Controls (IOC) was started in April. This included a requirement that the next 10 imported consignments from the implicated establishment would be subject to extra inspections.

Because of continued breaches of food safety requirements, this was escalated to Imposed Checks in May. These physical, documentary and testing inspections will remain in place until a minimum of 30 consecutive favorable results are achieved.

The UK importer has stopped receipt of the steam-cooked chicken product until the issue is resolved and is testing all their uncooked product on arrival into the UK for Salmonella. An investigation by Ukrainian authorities has resulted in risk management measures being taken at the facilities of the manufacturer.

In late 2022, the European Centre for Disease Prevention and Control (ECDC) reported that Finland had 89 cases while a few patients also lived in the Czech Republic, Estonia, France, Germany, Ireland, the Netherlands, and Israel.

RASFF Alerts – Salmonella – Polish Chicken Products – Sesame Seeds – Chicken leg Quarters – Smoked Sausage – Sock Samples – Rosette – Whole Egg Powder – Carne Fresca di Tacchino dalla Spagna

RASFF

Salmonella Enteritidis (in 4 out of 5 samples) fresh chicken leg quarters from Lithuania in Latvia

RASFF

Salmonella CO in chicken fillet from Poland in the Czech Republic

RASFF

Different types of Salmonella, including S. Enteritidis in poultry from Poland in Bulgaria

RASFF

Salmonella Enteritidis in socks samples in the chicken coop from Poland in Germany

RASFF

Salmonella in rosette from France in Belgium

RASFF

Salmonella in Indian Sesame seed in the Netherlands

RASFF

Salmonella spp. in whole egg powder from Bulgaria in Poland

RASFF

Salmonella spp. in chilled chicken breast from Poland in Italy

RASFF

Salmonella spp. from group O:9(D1) in frozen kebab made of poultry meat from Poland in Austria

RASFF

Presence of Salmonella spp. in Nigerian hulled sesame seeds in Greece, Turkey and Switzerland

RASFF

Salmonella Saintpaul in carne fresca di tacchino dalla Spagna from Spain in Italy

RASFF

Salmonella spp. in carnati de casa afumati (smoked sausages) from Romania in Hungary

RASFF

Salmonella spp. in sesame seeds from India in Poland

RASFF

Salmonella in marinated chicken sliced fillet from Poland in Estonia

USDA-FSIS Surveys Salmonella Rates in NRTE Breaded Stuffed Chicken Products

Food Safety.Com

As part of an effort to reduce cases of salmonellosis attributable to poultry products, the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) conducted a study with the Food Emergency Response Network (FERN) laboratories to gather data on not-ready-to-eat (NRTE) breaded stuffed chicken products purchased at retail stores. The release of the survey results follows FSIS’ April 2023 proposed determination to declare Salmonella an adulterant in breaded stuffed raw chicken products.

The survey was intended to gather information on the positive rate of Salmonella in NRTE breaded stuffed chicken products and any differences in laboratory methods used.

Through FERN, 11 geographically dispersed state labs participated in the study. From July 1, 2022—September 30, 2022, the labs purchased locally available NRTE breaded stuffed chicken products at retail stores (approximately 15 samples per month for each product) and tested them for the presence of Salmonella and indicator organisms.

In total, 58 of the 487 samples tested were positive for the presence of Salmonella. A noticeable difference in positivity rates was seen between laboratories that ran methods the same as FSIS (36 of 135, or 27 percent) using larger test portions and laboratories that ran methods different from FSIS (22 of 352, or 6 percent) using smaller test portions. Small amounts of Salmonella present in the product or uneven distribution of Salmonella contamination could account for the lower positivity rates when smaller sample portions were tested.

Total aerobic counts were similar across products tested. Whole genome sequencing detected S. Enteritidis (18 of 58), S. Infantis (22 of 58), S. Kentucky (15 of 58) and S. Typhimurium (3 of 58).